Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Stomach Neoplasms × Trifluridine × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 14 Colonic Neoplasms 4 Rectal Neoplasms 3 Stomach Neoplasms 1 Neoplasms 1 Neoplasm Metastasis 1 Gastric Cancer Adenocarcinoma Metastatic 1 Gallbladder Neoplasms 1 Clinical Stage III Gastric Cancer AJCC v8 1 Bile Duct Neoplasms 1

Interventions

Oxaliplatin 154 Capecitabine 104 Fluorouracil 91 Docetaxel 77 Cisplatin 76 S 1 (combination) 74 Leucovorin 63 Paclitaxel 52 Irinotecan 51 pembrolizumab 34 Trastuzumab 31 apatinib 29 sintilimab 28 Bevacizumab 20 Surgical Procedures, Operative 19 Radiotherapy 19 camrelizumab 15 Ramucirumab 14 Nivolumab 14 titanium silicide 13 tislelizumab 13 Drug Therapy 13 Hyperthermic Intraperitoneal Chemotherapy 12 Folfox protocol 12 Epirubicin 12 Cetuximab 12 Tegafur 10 Carboplatin 10 XELOX 9 HMPL-013 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07212933 2025-10-08

RAK in GC

Chinese PLA General Hospital

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡